Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 30th June 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Samrat Pharmachem Ltd. has submitted a compliance certificate under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018 for the quarter ending June 30, 2026. The certificate was issued by the company's Registrar and Transfer Agent (RTA), MUFG Intime India Pvt. Ltd. It confirms that all share certificates received for dematerialization during the quarter were properly processed and confirmed to the depositories. The physical certificates received were mutilated and cancelled, and the depositories' names have been substituted as registered owners in the company's records within the required timelines.
This is a routine quarterly compliance filing with no material impact on the business, financials, or shareholders. It simply confirms that the company's share dematerialization process is being handled correctly and within SEBI-prescribed timelines.